Specfic-locus experiments have previously shown nelphalan to be muagIck in all male germ-cell sas tested and particularly so in early spermatids. Al but 2 of 24 specifi-locus mut recovered were tested genetically, cytogenetically, and/or molecularly. At least 12 of 15 tested mutations recovered from -sts but only 1 of 7 mutations recovered from stem-cell or differentiating gave evidence of being delons or other rearra ets. Early germ-cell mutagenesis studies using the specific-locus test (SLT) were concerned primarily with determining whether a given treatment was mutagenic and with measuring mutation rates under various biological and/or physical treatment conditions (1, 2). However, the very design of the SLT-specifically, the inclusion of markers at two very closely linked loci-provided the means for obtaining at least crude qualitative information about the mutations recovered (3, 4). Over the decades, large numbers of independent mutations involving each of the loci were propagated in breeding stocks and analyzed genetically; complex sets of overlapping deletions were demonstrated, and units of functional significance were mapped in the regions surrounding several of the specific loci (5, 6). After molecular access to these regions was obtained, the overlapping deletions provided highly valuable reagents for fine-structure physical and functional mapping (7, 8) .
-sts but only 1 of 7 mutations recovered from stem-cell or differentiating gave evidence of being delons or other rearra ets. Melphalan-induced mutations, thus, confrm the pattern of dependence of mutation on germ-cell stage that had been shown earlier for other chmials. Results of the present invesillustrate the c es of combined genetic, cytogenetic, and molecular analyses for charaterizing the nature of specific-locus Finetructure molecular mang of long regions surrounding specific loci has been greatly f itated by the availability of genetic reagents (particularly, deletion complexes) generated in specific-locus experiments over the course of decades. Reciprocally, this ing permits incretingly detailed ch i of the nature of lesions induced by mutagenic exposures of germ cells, adding great powers for qualitative analysis of mutations to the specific-locus test. Cytogenetic and genetic inveslig ins also provide evidence on lesion type, ally for loi at which mutatios cannot yet be analyzed molecularly. Mdphalan, like chlorambucil, can generate many mutations, a high proportion of which are is and other r ngemets, making this c valuable for generating mutations (at any locus) amenable to mecular access.
Early germ-cell mutagenesis studies using the specific-locus test (SLT) were concerned primarily with determining whether a given treatment was mutagenic and with measuring mutation rates under various biological and/or physical treatment conditions (1, 2) . However, the very design of the SLT-specifically, the inclusion of markers at two very closely linked loci-provided the means for obtaining at least crude qualitative information about the mutations recovered (3, 4) . Over the decades, large numbers of independent mutations involving each of the loci were propagated in breeding stocks and analyzed genetically; complex sets of overlapping deletions were demonstrated, and units of functional significance were mapped in the regions surrounding several of the specific loci (5, 6) . After molecular access to these regions was obtained, the overlapping deletions provided highly valuable reagents for fine-structure physical and functional mapping (7, 8) .
The DNA probes that have been generated during this work are, in turn, furnishing the means for analyzing in more detail the structural nature of specific-locus mutations. In the simplest application these probes can be used to diagnose whether such mutations are deletions; but the molecular reagents are already available (and will become more numerous) for determining the extent of any deletions and for detecting other types of rearrangements associated with specific-locus mutations.
Before the present study, only selected radiation-induced mutations (for review, see ref. 8) and mutations induced by the chemical chlorambucil (CHL) (9) had been analyzed molecularly. By applying genetic criteria, specific-locus results obtained with several other chemicals, as well as with radiations, were retrospectively characterized as to the probable nature of the mutations (10, 11) . These various assessments have suggested that mutations induced in postspermatogonial stages are primarily large lesions (LLs), whereas those induced in spermatogonia are primarily "other" lesions (OLs) (i.e., not identifiable as deletions or other rearrangements by crude criteria) (11) .
Critical for such germ-cell-stage comparisons are agents that prove to be mutagenic both in spermatogonia and postspermatogonial stages. Melphalan (MLP) (Chemical Abstracting Service no. 148-82-3) has recently been added to a very short list of such chemicals (11, 12) . MLP resembles the closely related CHL in producing a high frequency of mutations in postspermatogonial stages, the peak mutagenic response being elicited by exposure of early spermatids (12, 13) . To date, these are the only two chemicals tested in the SLT that produce this "type-2" mutation-rate pattern (11) . CHL was found to induce almost exclusively LL mutations in postspermatogonial stages (9) . Such mutations can be valuable reagents for molecular analyses of genes or regions of interest throughout the genome.
Twenty-four mutations recovered from exposure of various male germ-cell stages to MLP are analyzed in the present study by using genetic, cytogenetic, and molecular techniques. By means of this combined characterization, we can demonstrate a major qualitative difference between mutations induced in spermatogonial and postspermatogonial stages; most of the latter, but only one of the former, gave evidence of being deletions or other rearrangements. METHODS The derivation of mutant mice is described elsewhere (12) . Each primary mutant was crossed with appropriate stocks to confirm allelism with one of the specific-locus markers. Confirmed mutations were propagated in breeding stocks. Crosses were made to generate homozygotes from each mutation; breeding protocols varied according to the locus at which the mutation had occurred (9) .
Abbreviations: MLP, melphalan; CHL, chlorambucil; SLT, specificlocus test; LL, large lesion; OL, other lesion.
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Presumed mutants that were sterile or had reduced numbers of offspring were studied cytogenetically in Giemsabanded mitotic metaphase preparations derived from cultured kidney fibroblasts (14) . For several of the mutants that transmitted chromosome rearrangements, meiotic preparations (15) were analyzed for multivalent associations in diakinesis/metaphase I.
High-molecular-weight DNA was obtained from distal tail-tip biopsies from either the primary mutants and/or their direct descendents. Southern blot analyses were done with probes for the b, c, and d loci by methods described for CHL-induced specific-locus mutations (9) .
RESULTS
Mutations Involving the Marker Loci. (18, 19) . Both bOR-sMm and bOR-3Mc are homozygous lethal (Table 1) . Analysis of the primary d-se-region mutants involved hybridizing Southern blots of EcoRI-digested mutant DNAs with probe p0.3, a 2.6-kb EcoRI-Pst I fragment derived from the site of the Emv-3 provirus integration within the d locus (20, 22) . Fig. 1C demonstrates that one d and two d se mutations were deleted for p0.3 (note the absence of the wild-type 9-kb EcoRI fragment in these mutants). Two of these mutations were homozygous lethal prenatally; the third (a d se) was untestable genetically because the primary mutant was sterile.
On the basis of cytogenetic evidence, an additional four mutations were also found to be gross rearrangements. These included a sterile s-locus mutant that had a deletion of bands 14D3-14E4 ( Fig. 2A) , which encompass the probable site of the s locus (23). Another sterile s mutant carried multiple reciprocal translocations, involving nine chromosomes (including chromosome 14, with the breakpoint in the general region thought to contain the s locus), as follows: T(1;11), T(2;14;15), T(5;10), and T(Y;16). A female a-locus mutant was found to have a chromosome-2 inversion with breakpoints in bands 2E1 and H1; the latter includes the probable 0 ::1. .tzj location of the a locus (23) . Offspring presumed to carry this rearrangement opposite a bp (bp, brachypody, is 0.3 centimorgan distal to a) had abnormal appendages (suggesting that the bp as well as the a locus were affected by the rearrangement), were extremely runty, and died before weaning. Significantly, a mutation at d that was not deleted for the 0.3 probe, dopOR-3Mf, was found to carry an inversion in chromosome 9, with one break in band 9E (Fig. 2B) , which probably contains the d locus (23) . The original mutant also carried a translocation that has segregated independently of the d-locus mutation (the chromosomes involved in the translocation have not yet been definitively identified). A number of chromosome rearrangements unrelated to the marker loci were also found. For example, one s-locus mutant, 50R-2M1, carried a translocation as well as a deletion, neither of which involved chromosome 14. In another stock derived from an s-locus mutant, 50R-2MS, semisterility segregated independently from the specific-locus mutation. Finally a b-locus mutant, bOR-SMm, carried a translocation involving chromosome 4, but with a breakpoint clearly distal to the b locus (Fig. 2C) ; this translocation subsequently segregated independently of the b-locus mutation.
In addition to the 10 mutants that, on the basis of molecular or cytogenetic evidence, can be classified as carrying deletions or other rearrangements involving a specific-locus marker, 3 others may probably be assigned to this group on the basis of genetic evidence. These include a homozygouslethal a' mutation and two homozygous-lethal s-locus mutations. [However, because there is as yet no positive proof that s is a nonvital locus, it cannot automatically be concluded-as it can for the other loci (8, 24)-that s lethals involve deletions of genes additional to the marker.] Two primary mutants (seOR-]Mm and sOR-SMf) died before test. A mottled male derived from matings made during week 7 after MLP treatment was mosaic for a p-locus mutation. Because the MLP-exposed cells were early-differentiating spermatogonia, which were still to undergo a number of cell divisions, the mosaic mutant (not shown in Table 1 (9, 13) . The effects of MLP are generally similar to those of CHL in terms of both overall mutation rate on a per-mol basis (12) and the high frequency of deletions and other rearrangements among the mutations induced in postspermatogonial stages.
Although 
